From Personal Loss to Scientific Mission:
For Jinfiniti founder, the pursuit of longevity began with personal tragedy. Growing up in the rural Chinese countryside, medical care was a rare luxury. After losing his young sister to a preventable illness, witnessing his father face a near-fatal health crisis and suffering a liver condition at the age of 20 himself, Dr. She vowed to master human biology to protect others from helpless loss.

A Career at the Frontiers of Genomic Medicine:
Driven by this mission, Dr. She earned his PhD in Molecular Genetics. Over a spectacular 40-year academic career in the United States, he became a global authority in personalized medicine:

* Academic Leadership: Served as Endowed Full Professor and multiple national and international medical leadership positions.

* Pioneering Innovation: Recruited as a Georgia Research Alliance Eminent Scholar, he founded the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia.

* Global Impact: Authored almost 500 peer-reviewed papers with a H-index of 82, secured $100M+ in research funding, and directed major national and international research programs.

The Birth of Jinfiniti:
Despite his tremendous academic success, Dr. She grew frustrated by traditional healthcare, which merely manages chronic decline. Recognizing that the root causes of disease are the exact drivers of cellular aging, he left academia to close the 30-year gap between lifespan and healthspan.

Becoming his own patient, he developed the world’s first consumer intracellular NAD+ test and advanced longevity biomarker panels. Today, Jinfiniti pairs cutting-edge functional data with precision protocols to shift medicine from reactive treatment to proactive cellular vitality.